CHF
Pulmonology
GI
A. Fib
OSA
100

EF at which ICD placement is indicated, if patient is on GDMT and has NYHA Class II or III symptoms.

<35%

100

Spirometry value required for the diagnosis of COPD

FVC/FEV1 >70%

100

Initial diagnostic test for patients with oropharyngeal dysphagia

Videofluoroscopy (or modified barium swallow)

100

Paroxysmal AF stops spontaneously within this time frame.

7 days

100

AHI is an acronym for these words

Apnea-Hypopnea Index

200

In the RALES trial this medicine showed a significant reduction in the primary outcome of all-cause mortality in patients with CHF NYHA III-IV and EF<35%.

Spironolactone

200

Preferred outpatient empiric therapy for community-acquired pneumonia.

Monotherapy with doxycycline or amoxicillin

200

Solid and liquid dysphagia, "birds beak" appearance on barium swallow, confirmed with esophageal manometry.

Achalasia

200

Duration of anticoagulation required following cardioversion (at least this amount of time).

At least 4 weeks

200

AHI cutoffs for mild, moderate, and severe OSA

5, 15, and 30 per hour

300

This trial established the superiority of sucubatril/valartan over enalpril, showing a 20% RRR and 4.7% ARR in CV mortality and hospitalization due to heart failure.

PARADIGM-HF

300

This preferred scoring system predicts 30 day all-cause morality for patient with pneumonia, examining 11 variables including co-existing illnesses.

PSI (pneumonia severity index)

300

Post-surgical cause of UGI bleed in patients with prior aortic graft surgery.

Aortoenteric fistula

300

These 2 conditions receive 2 points when calculating CHA2DS2VASc. All other conditions receive 1 point.

Prior stroke or TIA and age >/= 75.

300

The most prominent risk factor for OSA

Obesity

400

The three beta-blockers showing mortality benefit in HFrEF

Bisoprolol, carvedilol, and metoprolol succinate

400

Common recommended tidal volume settings that were established through the ARDSNET trial.

4-8 mL/kg predicted body weight

400

Indication for fecal occult blood testing in a hospitalized patient

NONE, nada, nil, zero, zilch. 

You can try to name one... but you'd better be prepared to come at me, Bro.

400

Antiplatelet/antithrombotic combination recommended for patients with AF undergoing PCI.

DOAC + P2Y12 (specifically clopidogrel or ticagrelor)  (Favored over triple therapy with DOAC + P2Y12 + ASA)

400

Nasal end-expiratory positive airway pressure device named after a musical instrument.

Bongo

500

In patients with chronic symptomatic heart failure and EF<35% who are in sinus rhythm taking maximally tolerated doses of a beta blocker, this sinoatrial node stimulator reduces heart failure-associated hospitalizations and the combined endpoint of mortality and heart failure hospitalization.

Ivabradine

500

Duration of steroids for COPD exacerbation are directed by this landmark trial.

REDUCE

500

Potential  cause of lower GI bleed in patient with Aortic Stenosis. *Brownie points awarded for also naming the syndrome.

Angiodysplasia (Heyde Syndrome)

*Brownie points cannot be redeemed for actual Jeopardy points!

500

This trial showed improved outcomes (CV death, stroke, hospitalization) with early rhythm control (drugs or ablation) compared to usual care in high risk patients.

EAST-AFNET 4 trial

500

A RTC examining the effect of playing this musical instrument showed a reduction in AHI from 22 to 12 in patients with OSA.

Didgeridoo